Crowdtells

Culture Kalshi September 1, 2026 Crowd ahead of press

Medtronic Posts Strong Earnings, Investment Spurs Speculation

What will Medtronic say during their next earnings call?

Kalshi prices this Sphere-9 at 99%. The market is more confident than the current reporting.

Medtronic reported robust first-quarter fiscal 2027 results, exceeding analyst estimates and raising its full-year guidance, driven by broad-based portfolio performance. The medical device giant also revealed a substantial $700 million investment in robot surgeon technology, intensifying competition with rivals like Intuitive Surgical. This strong financial showing and strategic move have drawn attention to the company's upcoming communications, with traders putting the probability of Medtronic mentioning "Sphere-9" during its next earnings call at 99%, a figure that has notably climbed by +7 pts in the past 24 hours.

Background

Medtronic, a global leader in medical technology, has been under scrutiny from investors following a bullish call from Bank of America on the 77-year-old healthcare stock. The company's recent earnings calls are closely watched for insights into its strategic direction and product development, particularly as it navigates a competitive landscape in medical devices. The specific term "Sphere-9" has emerged as a point of interest, with its mention on an earnings call seen as a potential indicator of a new product or significant development. The current prediction market, which has seen its odds for a "Sphere-9" mention rise steadily, is set to resolve in approximately 121 days.

The precedent

Context compiled by Crowdtells from the public record — verify before relying on it.

What the coverage agrees on

  • Medtronic exceeded Q1 2026 earnings estimates.
  • The company raised its fiscal 2027 guidance.
  • Medtronic made a significant investment in robot surgeon technology.

How outlets frame it

  • Barron's: Emphasizes Medtronic's competitive position against Intuitive Surgical following its robot surgeon investment.
  • Yahoo Finance: Highlights a prior bullish call on Medtronic by Bank of America, setting a positive long-term outlook.

What to watch

Medtronic's next earnings call, which was scheduled 86 minutes ago, will be closely scrutinized for any mention of "Sphere-9" by company representatives. The company's recent financial performance and its substantial investment in robotic surgery suggest a period of active development and communication. Any explicit reference to "Sphere-9" during the call or its Q&A session would resolve the market to "Yes," confirming a specific strategic or product focus.

The numbers behind this

Kalshi prices this Sphere-9 at 99%.

24h +7.0 pts

$26.3K traded · $20.9K in the last day · $20.5K open interest

Resolves on: If Sphere-9 is said by any Medtronic representative (including the operator of the call) during the next Medtronic earnings call (including the Q+A), then the market resolves to Yes.

Pricing Kalshi 99%

See live odds & discussion →

Sources

Frequently asked questions

What will Medtronic say during their next earnings call?

Kalshi prices this Sphere-9 at 99%. The market is more confident than the current reporting.

What do the sources agree on?

Medtronic exceeded Q1 2026 earnings estimates. The company raised its fiscal 2027 guidance. Medtronic made a significant investment in robot surgeon technology.

When does this market resolve?

This market resolves on: If Sphere-9 is said by any Medtronic representative (including the operator of the call) during the next Medtronic earnings call (including the Q+A), then the market resolves to Yes.

How are these odds set?

Prediction-market odds are prices set by people trading real money on the outcome, so the price reads as the crowd’s implied probability — not a guarantee or financial advice.

AI-written briefing grounded in 5 sources and the live market, edited by Samuel Jo. Odds are crowd probabilities, not advice — how this works.